A Study to Assess the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Pharmacodynamics of JNJ-64179375 in Healthy Japanese Participants
Clinical trial NCT03080987 · COMPLETED
Trial details
- NCT number
- NCT03080987
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-27
- Primary completion
- 2018-06-25
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.